Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from double ritonavir-boosted protease inhibitors to darunavir/ritonavir in virologically suppressed HIV patients
2007-000932-19Phase 4Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of darunavir in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Primary endpoint: Virologic suppression at week 48. Started Apr 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-000932-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000932-19.